Transcutaneous spinal cord stimulation with 4-aminopyridine and intensive rehab for chronic spinal cord injury
Official title: Combination Therapy: Transcutaneous Spinal Stimulation (TSS), 4 Aminopyridine (4 AP), and Intensive Rehabilitation for Motor Recovery After Spinal Cord Injury
Run by TryAbility LLC · NCT07922122 · Data updated 2026-11-12
This pilot study tests whether combining noninvasive spinal stimulation, dalfampridine, and rigorous rehab is safe and feasible for adults with chronic spinal cord injury and whether it can help improve movement and walking.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 8 (estimated) |
| Sponsor | TryAbility LLC Academic / other |
| Locations | 1 site (Downers Grove, Illinois) |
| Status | Recruiting |
| Started | June 6, 2026 |
| Main results expected | July 8, 2027 |
| Study ends | September 8, 2027 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07922122 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–75 with chronic SCI (≥12 months post-injury), medically stable, currently prescribed dalfampridine, and able to participate in intensive rehabilitation.
✕Probably not a fit
Patients not experiencing functional improvements or who have contraindications to dalfampridine or electrical stimulation may see no meaningful benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, single-arm pilot study will enroll eight adults with chronic spinal cord injury (at least 12 months post-injury) to receive a 12-week outpatient program combining transcutaneous spinal cord stimulation, dalfampridine, and intensive physical and occupational therapy. The objective is to assess safety and feasibility of the combined approach in a real-world rehabilitation setting and to explore preliminary changes in upper and lower extremity motor function, strength, ambulation, balance, and functional mobility. Participants will undergo about three treatment sessions per week, each session including 60 minutes of physical therapy and 60 minutes of occupational therapy, alongside ongoing dalfampridine as prescribed by their treating physician. The study builds on the rationale that neuromodulation and pharmacologic augmentation may enhance activity-dependent neuroplasticity when paired with task-specific rehabilitation. Outcomes from this pilot will inform whether this multimodal strategy merits further investigation in larger, controlled trials.
Why it matters
Potential benefit: If successful, participants may experience improvements in motor function and mobility, potentially translating to better independence in daily activities.
How similar studies have gone: Previous work suggests neuromodulation and pharmacologic strategies can support motor activation after SCI, but this specific combination is novel and at the feasibility stage.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Adults between 18 and 75 years of age. Diagnosis of chronic spinal cord injury (SCI), at least 12 months post-injury. Medically stable and able to participate in intensive rehabilitation therapy. Able to provide informed consent. Currently receiving 4-aminopyridine (dalfampridine) prescribed by their treating physician as part of routine medical care. Criteria: \- Exclusion Criteria: * History of uncontrolled seizure disorder. Contraindication to 4-aminopyridine (dalfampridine). Uncontrolled cardiovascular disease. Presence of implanted electrical medical devices, including pacemakers or neurostimulators. Pregnancy. Severe pressure injuries that prevent safe electrode placement. Known or suspected significant cognitive impairment, dementia, intellectual disability, or other neurological or psychiatric conditions that interfere with comprehension of study requirements or the ability to complete study assessments.
Where it's running
-
TryAbility Neuro Recovery Center
Downers Grove, Illinois, United States Recruiting
Study contacts
- Principal investigator: Sakina Valika, DPT — TryAbility NeuroRecovery Centr
- Study coordinator: Sakina Valika, DPT
- Email: sakina@tryabilityrehab.com
- Phone: 331-775-2813
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NG004 for incomplete cervical spinal cord injury
This trial tests NG004 versus placebo to see if it is safe and helps motor function and daily life in adults with acute incomplete cervical spinal cord injury.
-
Robot-assisted training for arm and leg movement after stroke or injury
This study tests whether adding ZEPU-AI robotic training to usual therapy is safe and helps adults with arm or leg movement problems from stroke, spinal cord injury, brain injury, or orthopedic conditions.
-
ZEPU-AI3 Lower Limb Feedback Training and Evaluation Robot in Rehab
This pilot trial tests whether adding the ZEPU-AI3 robotic leg training with real-time feedback to standard rehab helps adults with lower limb motor problems from stroke, spinal cord injury, or similar conditions.
-
Combined magnetic stimulation and ultrasound for detrusor overactivity in spinal cord injury
This study tests whether using high-frequency sacral nerve stimulation together with bladder-directed ultrasound can reduce involuntary bladder contractions and improve bladder function in people with spinal cord injury.
-
Hybrid HIIT-FES cycling program for people with spinal cord injury
This study tests a hybrid exercise program that combines functional electrical stimulation cycling with voluntary arm work to improve health in adults with spinal cord injury.
-
Hands-free self-balancing exoskeleton to help walking after spinal cord injury
This study will try a hands-free, self-balancing exoskeleton in adults with spinal cord injury to see if it safely helps with standing and walking in daily life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.